Literature DB >> 2069713

Evaluation of the evidence that tobacco-specific nitrosamines (TSNA) cause cancer in humans.

S Preston-Martin1.   

Abstract

Considerable evidence exists that TSNA may cause cancer in humans. Strong evidence suggests that the NNN and NNK in snuff are at least partially responsible for the excess of oral cancer among snuff dippers. Tobacco smoke, because it is a combustion product, is a far more complex matrix than is smokeless tobacco. Nonetheless, NNK is well established as a lung carcinogen in laboratory animals at levels similar to those experienced by heavy smokers. Although the epidemiology of the smoking/lung cancer association has been studied extensively and is well established as a causal relationship, few attempts have been made to determine the effective constituents in tobacco smoke, much less to quantify them and to reduce their levels in consumer products. More work is needed to determine TSNA uptake in smokers and users of smokeless tobacco and to determine the factors involved in the possible endogenous formation of TSNA and in their metabolic activation or inhibition of their formation. Exploratory work is in progress with various biological markers that may prove useful in quantifying the levels of TSNA exposure in humans. Epidemiologic evidence indicates that in addition to tobacco use other factors are causally related to the development of cancers of the oral cavity, lung and esophagus and that these factors (e.g., radon exposure in uranium miners who smoke) can act synergistically. Experimental investigation of some of these synergistic effects may prove to be a step in the direction of determining the proportion of various cancers that are likely to be attributable to various causes and ultimately to the various constituents of tobacco exposure.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2069713     DOI: 10.3109/10408449109017915

Source DB:  PubMed          Journal:  Crit Rev Toxicol        ISSN: 1040-8444            Impact factor:   5.635


  6 in total

1.  Public health implications of smokeless tobacco use as a harm reduction strategy.

Authors:  David A Savitz; Roger E Meyer; Jason M Tanzer; Sidney S Mirvish; Freddi Lewin
Journal:  Am J Public Health       Date:  2006-10-03       Impact factor: 9.308

2.  Exposure to high concentrations of nitrosamines and cancer mortality among a cohort of rubber workers.

Authors:  K Straif; S K Weiland; M Bungers; D Holthenrich; D Taeger; S Yi; U Keil
Journal:  Occup Environ Med       Date:  2000-03       Impact factor: 4.402

3.  Mutant genes of cytochrome P-450IID6, glutathione S-transferase class Mu, and arylamine N-acetyltransferase in lung cancer patients.

Authors:  I Roots; J Brockmöller; N Drakoulis; R Loddenkemper
Journal:  Clin Investig       Date:  1992 Mar-Apr

4.  Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008.

Authors:  Nicholas Donin; Christopher Filson; Alexandra Drakaki; Hung-Jui Tan; Alex Castillo; Lorna Kwan; Mark Litwin; Karim Chamie
Journal:  Cancer       Date:  2016-07-05       Impact factor: 6.860

5.  Characterization of Pseudooxynicotine Amine Oxidase of Pseudomonas putida S16 that Is Crucial for Nicotine Degradation.

Authors:  Haiyang Hu; Weiwei Wang; Hongzhi Tang; Ping Xu
Journal:  Sci Rep       Date:  2015-12-04       Impact factor: 4.379

6.  Compositional Differences in the Oral Microbiome of E-cigarette Users.

Authors:  Jessica Chopyk; Christine M Bojanowski; John Shin; Alex Moshensky; Ana Lucia Fuentes; Saniya S Bonde; Dagni Chuki; David T Pride; Laura E Crotty Alexander
Journal:  Front Microbiol       Date:  2021-05-31       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.